Loading...
Engineered Dual Antioxidant Enzyme Complexes Targeting ICAM-1 on Brain Endothelium Reduce Brain Injury-Associated Neuroinflammation
Leonard, Brian M. Shuvaev, Vladimir V. Bullock, Trent A. Udeni Galpayage Dona, Kalpani N. Muzykantov, Vladimir R. Andrews, Allison M. Ramirez, Servio H.
Leonard, Brian M.
Shuvaev, Vladimir V.
Bullock, Trent A.
Udeni Galpayage Dona, Kalpani N.
Muzykantov, Vladimir R.
Andrews, Allison M.
Ramirez, Servio H.
Citations
Altmetric:
Genre
Journal article
Date
2024-02-21
Advisor
Committee member
Department
Pathology and Laboratory Medicine
Permanent link to this record
Collections
Files
Research Projects
Organizational Units
Journal Issue
DOI
https://doi.org/10.3390/bioengineering11030200
Abstract
The neuroinflammatory cascade triggered by traumatic brain injury (TBI) represents a clinically important point for therapeutic intervention. Neuroinflammation generates oxidative stress in the form of high-energy reactive oxygen and nitrogen species, which are key mediators of TBI
pathology. The role of the blood–brain barrier (BBB) is essential for proper neuronal function and is vulnerable to oxidative stress. Results herein explore the notion that attenuating oxidative stress at the vasculature after TBI may result in improved BBB integrity and neuroprotection. Utilizing amino-chemistry, a biological construct (designated “dual conjugate” for short) was generated by covalently binding two antioxidant enzymes (superoxide dismutase 1 (SOD-1) and catalase (CAT)) to antibodies specific for ICAM-1. Bioengineering of the conjugate preserved its targeting and enzymatic functions, as evaluated by real-time bioenergetic measurements (via the Seahorse-XF platform), in brain endothelial cells exposed to increasing concentrations of hydrogen peroxide or a superoxide anion donor. Results showed that the dual conjugate effectively mitigated the mitochondrial stress due to oxidative damage. Furthermore, dual conjugate administration also improved BBB and endothelial protection under oxidative insult in an in vitro model of TBI utilizing a software-controlled stretching device that induces a 20% in mechanical strain on the endothelial cells. Additionally, the dual conjugate was also effective in reducing indices of neuroinflammation in a controlled cortical impact (CCI)-TBI animal model. Thus, these studies provide proof of concept that targeted dual antioxidant biologicals may offer a means to regulate oxidative stress-associated cellular damage during neurotrauma.
Description
Citation
Leonard, B.M.; Shuvaev, V.V.; Bullock, T.A.; Galpayage Dona, K.N.U.; Muzykantov, V.R.; Andrews, A.M.; Ramirez, S.H. Engineered Dual Antioxidant Enzyme Complexes Targeting ICAM-1 on Brain Endothelium Reduce Brain InjuryAssociated Neuroinflammation. Bioengineering 2024, 11, 200. https://doi.org/10.3390/bioengineering11030200
Citation to related work
MDPI
Has part
Bioengineering, Vol. 11, Iss. 3
ADA compliance
Embedded videos
License
Attribution CC BY